Vontobel Holding Ltd. Buys Shares of 62,006 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Vontobel Holding Ltd. purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 62,006 shares of the company’s stock, valued at approximately $4,794,000.

Several other large investors have also modified their holdings of the business. Armstrong Henry H Associates Inc. lifted its stake in shares of GE HealthCare Technologies by 3.9% in the 3rd quarter. Armstrong Henry H Associates Inc. now owns 4,105 shares of the company’s stock valued at $279,000 after purchasing an additional 153 shares during the last quarter. Chicago Capital LLC lifted its stake in shares of GE HealthCare Technologies by 2.8% in the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after purchasing an additional 163 shares during the last quarter. Chilton Capital Management LLC lifted its stake in shares of GE HealthCare Technologies by 15.4% in the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after purchasing an additional 164 shares during the last quarter. Procyon Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 5.2% in the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after purchasing an additional 175 shares during the last quarter. Finally, Meeder Advisory Services Inc. lifted its stake in shares of GE HealthCare Technologies by 5.4% in the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after purchasing an additional 185 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the topic of several research reports. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their target price for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Citigroup increased their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Argus increased their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Mizuho increased their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, April 11th. Finally, HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.08.

Get Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Trading Down 0.8 %

GEHC opened at $85.19 on Thursday. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a market cap of $38.87 billion, a P/E ratio of 28.21, a PEG ratio of 3.00 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The business’s 50-day simple moving average is $88.61 and its 200-day simple moving average is $77.65.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter in the prior year, the business posted $1.31 EPS. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Further Reading

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.